News & Comment

The US Food and Drug Administration (FDA) has approved sotagliflozin with a broad heart-failure indication, even in the absence of trial data in patients without diabetes. No one knows what the benefits or risks of inhibiting SGLT1 in the heart might be.

Sotatercept is the first successful therapy to make it through phase 3 to regulatory submission in pulmonary arterial hypertension that is not proposed to work via vasodilatory mechanisms. The phase 3 STELLAR study of sotatercept treatment challenges established thinking on pulmonary vascular remodeling and offers patients hope for a step change in outcomes.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Mariona Graupera.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Anna Randi.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Rebekah Gundry.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Stefanie Dimmeler.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Cornelia Weyand.

During March 2023, Nature Cardiovascular Research celebrates the female scientists that published with us last year, by reporting a brief story of their scientific and life journey. As we celebrate these extraordinary women through their fascinating stories, we hope to inspire younger generations that are starting their own amazing journey in life sciences. Each scientist featured in this article series has received an identical set of five questions. Although their backgrounds and journeys are unique, there is a common thread in their narratives — they are all insatiably curious, their generosity is bottomless and their love for science is profound. Here, we present Sabine Steffens.